Immunomedics, Inc. to Present at Upcoming Healthcare Conferences

MORRIS PLAINS, N.J., Feb. 22, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company’s senior management will be presenting at two upcoming healthcare conferences:

MORE ON THIS TOPIC